[Expert consensus statement on Danshen Chuanxiongqin Injection in clinical practice]

Area of Science:

• Cardiovascular Medicine
• Cerebrovascular Medicine
• Pharmacology

Background:

• Danshen Chuanxiongqin Injection is frequently used for cerebral infarction and coronary heart disease.
• It is recommended by numerous guidelines for cardiovascular and cerebrovascular conditions.
• Irrational clinical drug use can reduce efficacy and increase safety risks.

Purpose of the Study:

• To establish expert consensus recommendations for the rational clinical use of Danshen Chuanxiongqin Injection.
• To address issues of irrational drug use affecting treatment outcomes and patient safety.
• To provide evidence-based guidance for healthcare professionals.

Main Methods:

• A nominal group method was employed, integrating clinical research evidence and expert experience.
• Experts collaborated to determine consensus suggestions on drug application.
• Key areas addressed include indications, timing, administration, dosage, and treatment duration.

Main Results:

• The consensus outlines specific recommendations for the indications of Danshen Chuanxiongqin Injection.
• Guidance is provided on optimal intervention time, route of administration, dosage, and treatment course.
• The consensus also addresses safety considerations for clinical application.

Conclusions:

• This expert consensus offers crucial guidance for the appropriate clinical use of Danshen Chuanxiongqin Injection.
• Adherence to these recommendations can enhance treatment efficacy for cardiovascular and cerebrovascular diseases.
• Implementing the consensus guidelines will mitigate safety risks associated with irrational drug use.